A detailed history of Hartford Investment Management CO transactions in Viatris Inc stock. As of the latest transaction made, Hartford Investment Management CO holds 77,198 shares of VTRS stock, worth $796,683. This represents 0.03% of its overall portfolio holdings.

Number of Shares
77,198
Previous 81,038 4.74%
Holding current value
$796,683
Previous $877,000 5.02%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$11.27 - $13.53 $43,276 - $51,955
-3,840 Reduced 4.74%
77,198 $921,000
Q4 2023

Jan 23, 2024

SELL
$8.77 - $10.85 $17,180 - $21,255
-1,959 Reduced 2.36%
81,038 $877,000
Q3 2023

Oct 16, 2023

SELL
$9.59 - $11.35 $19,429 - $22,995
-2,026 Reduced 2.38%
82,997 $818,000
Q2 2023

Jul 19, 2023

SELL
$9.02 - $10.29 $164,353 - $187,494
-18,221 Reduced 17.65%
85,023 $848,000
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $134,651 - $179,437
14,636 Added 16.52%
103,244 $993,000
Q4 2022

Jan 20, 2023

SELL
$8.72 - $11.56 $244,029 - $323,506
-27,985 Reduced 24.0%
88,608 $986,000
Q3 2022

Nov 02, 2022

BUY
$8.48 - $11.13 $4,842 - $6,355
571 Added 0.49%
116,593 $993,000
Q2 2022

Jul 22, 2022

BUY
$9.95 - $12.27 $19,193 - $23,668
1,929 Added 1.69%
116,022 $1.22 Million
Q1 2022

Apr 20, 2022

SELL
$9.81 - $15.4 $86,524 - $135,828
-8,820 Reduced 7.18%
114,093 $1.24 Million
Q4 2021

Feb 02, 2022

BUY
$12.09 - $14.68 $123,172 - $149,559
10,188 Added 9.04%
122,913 $1.66 Million
Q3 2021

Nov 01, 2021

BUY
$13.25 - $15.13 $1.49 Million - $1.71 Million
112,725 New
112,725 $1.53 Million
Q2 2021

Jul 29, 2021

SELL
$12.97 - $16.15 $1.71 Million - $2.13 Million
-132,179 Closed
0 $0
Q1 2021

Apr 21, 2021

BUY
$13.59 - $18.54 $1.8 Million - $2.45 Million
132,179 New
132,179 $1.85 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.